Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 1:12:642877.
doi: 10.3389/fneur.2021.642877. eCollection 2021.

Impact of Clot Shape on Successful M1 Endovascular Reperfusion

Affiliations

Impact of Clot Shape on Successful M1 Endovascular Reperfusion

Adrien Guenego et al. Front Neurol. .

Abstract

Objectives: The susceptibility-vessel-sign (SVS) allows thrombus visualization, length estimation and composition, and it may impact reperfusion during mechanical thrombectomy (MT). SVS can also describe thrombus shape in the occluded artery: in the straight M1-segment (S-shaped), or in an angulated/traversing a bifurcation segment (A-shaped). We determined whether SVS clot shape influenced reperfusion and outcomes after MT for proximal middle-cerebral-artery (M1) occlusions. Methods: Between May 2015 and March 2018, consecutive patients who underwent MT at one comprehensive stroke center and who had a baseline MRI with a T2* sequence were included. Clinical, procedural and radiographic data, including clot shape on SVS [angulated/bifurcation (A-SVS) vs. straight (S-SVS)] and length were assessed. Primary outcome was successful reperfusion (TICI 2b-3). Secondary outcome were MT complication rates, MT reperfusion time, and clinical outcome at 90-days. Predictors of outcome were assessed with univariate and multivariate analyses. Results: A total of 62 patients were included. 56% (35/62) had an A-SVS. Clots were significantly longer in the A-SVS group (19 mm vs. 8 mm p = 0.0002). Groups were otherwise well-matched with regard to baseline characteristics. There was a significantly lower rate of successful reperfusion in the A-SVS cohort (83%) compared to the S-SVS cohort (96%) in multivariable analysis [OR 0.04 (95% CI, 0.002-0.58), p = 0.02]. There was no significant difference in long term clinical outcome between groups. Conclusion: Clot shape as determined on T2* imaging, in patients presenting with M1 occlusion appears to be a predictor of successful reperfusion after MT. Angulated and bifurcating clots are associated with poorer rates of successful reperfusion.

Keywords: clot; endovascular recanalization; magnetic resonance imaging; stroke; thrombectomy.

PubMed Disclaimer

Conflict of interest statement

GA reports equity and consulting for iSchemaView and consulting from Medtronic. MM reports Ownership Interest in ThrombX Medical. JH reports Consultant or Advisory Board for Medtronic, Inc., MicroVention, Inc., and iSchemaView. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Illustrations of SVS shape in an angulated (A-shaped) branch [either in an MCA bifurcation [a], or an angulated M1–M2 [b]] or in a straight [S-shaped [c]] branch. (A) Susceptibility vessel sign in a M1 segment seen as a linear hypo-intensity branch, dividing into two clots within the M2 middle cerebral artery branches. (B) Susceptibility vessel sign in a M1 segment seen as a horizontal hypo-intensity in the M1 branch, continuing with a 90° angle in the M1/M2 branch. (C) Susceptibility vessel sign in a M1 segment seen as a linear/straight hypo-intensity in the M1 branch (I).
Figure 2
Figure 2
Flow-chart. Number of patients screened then included according to our inclusion criteria: Initial database 352 patients; among them 172 had a proximal MCA (M1) occlusion; 101 of them were screened by MRI, and 71 were screened by CT scan and excluded; 62 patients had A SVS on their GRE imaging.

References

    1. Goyal M, Menon BK, Van Zwam WH, Dippel DWJ, Mitchell PJ, Demchuk AM, et al. . Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. (2016) 387:1723–31. 10.1016/S0140-6736(16)00163-X - DOI - PubMed
    1. Marks MP, Heit JJ, Lansberg MG, Kemp S, Christensen S, Derdeyn CP, et al. . Endovascular treatment in the DEFUSE 3 study. Stroke. (2018) 49:2000–3. 10.1161/STROKEAHA.118.022147 - DOI - PMC - PubMed
    1. Baek JH, Kim BM, Kim DJ, Heo JH, Nam HS, Song D, et al. . Importance of truncal-type occlusion in stentriever-based thrombectomy for acute stroke. Neurology. (2016) 87:1542–50. 10.1212/WNL.0000000000003202 - DOI - PubMed
    1. Consoli A, Rosi A, Coskun O, Nappini S, Di Maria F, Renieri L, et al. . Thrombectomy for M1-middle cerebral artery occlusion: angiographic aspect of the arterial occlusion and recanalization: a preliminary observation. Stroke. (2018) 49:1286–9. 10.1161/STROKEAHA.117.018987 - DOI - PubMed
    1. Naggara O, Raymond J, Domingo Ayllon M, Al-Shareef F, Touze E, Chenoufi M, et al. . T2* “susceptibility vessel sign” demonstrates clot location and length in acute ischemic stroke. PLoS ONE. (2013) 8:e76727. 10.1371/journal.pone.0076727 - DOI - PMC - PubMed

LinkOut - more resources